Coherent Market Insights published a business research report on Precision Medicine Software Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Precision Medicine Software Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
The global Precision Medicine Software Market analysis further provides pioneering landscape of market along with market augmentation history and key development involved in the industry. The report also features comprehensive research study for high growth potential industries professional survey with market analysis. Precision Medicine Software Market report helps the companies to understand the market trends and future market prospective,opportunities and articulate the critical business strategies.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2683
Precision medicine software is an emerging approach used to prevent and treat diseases such as rare illness, cancer, and infectious diseases. It is a combination of techniques and molecular biology systems. These techniques or systems help physicians to monitor the patient efficiently. Precision medicine software is used for genetic research and advances in genomics.
Frequent launches of novel software are expected to augment the growth of the global precision medicine software market over the forecast period. For instance, in January 2019, XIFIN Inc. announced the launch of VisualStrata, the precision medicine informatics platform that curates and visualizes diagnostic, clinical and financial data to document the patient journey through diagnosis, treatment, and outcomes.
Moreover, introduction of novel genomic tools is expected to boost the growth of the global precision medicine software market over the forecast period. For instance, in September 2018, Ariel Precision Medicine announced the launch of ArielDx, a cloud-based clinical decision support tool designed to simplify the diagnosis and treatment of pancreatic disease.
Furthermore, increasing prevalence of cancer and infectious diseases is expected to propel the growth of the global precision medicine software market. For instance, in April 2018, NuProbe raised US$ 11 million to continue development of ultra-sensitive, non-invasive blood test for the early detection of cancer and infectious diseases.
Product recall is expected to hamper growth of the global precision medicine software market. For instance, in January 2018, Phillips Medical System Inc., received product recall letter from FDA for its Brilliance Big Core CT.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2683
By Delivery Type:
- On Premise
- Rare Diseases
By End Users:
- Research Centers
- Government Institutes
- Pharmaceutical and Biotechnological Companies
- North America
- Asia Pacific
- Latin America
- Middle East
North America is expected to witness robust growth in the global precision medicine software market due to the increasing adoption of precision medicine software/platform and favorable government initiatives in the region. For instance, in January 2019, Fitbit and the National Institutes of Health (NIH) launched the Fitbit Bring-Your-Own-Device (BYOD) project, the first digital health technology initiative for the All of Us Research Program. Fitbit is the first wearable to be included in the program. Moreover, in November 2016, the American Heart Association (AHA), in collaboration with Amazon Web Services (AWS), launched the global, secure cloud-based data marketplace to access and analyze rich and diverse data to accelerate solutions for cardiovascular diseases — the No. 1 cause of death worldwide.
Furthermore, Asia Pacific is also expected to witness significant growth in the global precision medicine software market due to the increasing adoption of precision medicine. For instance, in September 2018, Konica Minolta, Inc. launched its new business in precision medicine in Japan to develop novel technologies, medicine platform, and discover new therapies.
Major players active in the global precision medicine software market are NantHealth, Inc., LifeOmic Health, LLC, Gene42, Inc., SOPHiA GENETICS SA, Fabric Genomics, 2bPrecise LLC, Syapse, Inc., Koninklijke Philips N.V., and Foundation Medicine, Inc., among others.
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/2683
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Precision Medicine Software Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Precision Medicine Software Industry Impact
Chapter 2 Global Precision Medicine Software Competition by Types, Applications, and Top Regions and Countries
2.1 Global Precision Medicine Software (Volume and Value) by Type
2.3 Global Precision Medicine Software (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Precision Medicine Software Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Precision Medicine Software Market Analysis
Chapter 6 East Asia Precision Medicine Software Market Analysis
Chapter 7 Europe Precision Medicine Software Market Analysis
Chapter 8 South Asia Precision Medicine Software Market Analysis
Chapter 9 Southeast Asia Precision Medicine Software Market Analysis
Chapter 10 Middle East Precision Medicine Software Market Analysis
Chapter 11 Africa Precision Medicine Software Market Analysis
Chapter 12 Oceania Precision Medicine Software Market Analysis
Chapter 13 South America Precision Medicine Software Market Analysis
Chapter 14 Company Profiles and Key Figures in Precision Medicine Software Business
Chapter 15 Global Precision Medicine Software Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027